Search Results 2211-2220 of 17724 for rheumatoid arthritis

  1. Skin Cancer Clinical Trials - Mayo Clinic Research

    ... Rheumatic Immune-related Adverse Events While Receiving Treatment for Melanoma Rochester, MN ... Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM- ...

  2. Postoperative Infections Clinical Trials

    ... Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite the use of ...

  3. Publications - Deborah J. Rhodes, M.D. - Mayo Clinic

    ... factor: a case-control study. Breast Cancer Res. 2016 Apr 26; 18 (1):42. View PubMed; Conners AL, Jones KN, Hruska CB, Geske JR, Boughey JC, Rhodes DJ. Direct ...

  4. Cellular and Molecular Endocrinology Research - Division of Endocrinology, Diabetes, Metabolism, and Nutrition-Research - Mayo Clinic Research

    Autoimmune thyroid disease; Bone metabolism; Calcium in atherogenesis; Growth factor regulation; Molecular medicine approaches in cancer treatment; Muscle ...

  5. Spinal cord injury - Doctors and departments - Mayo Clinic

    ... Arthritis, Dystonia, Charcot-Marie-Tooth disease, Angelman syndrome, Foot drop, Flatfeet, In-toeing, Neurologic muscle weakness, Neuropathy, Autoimmune ...

  6. Rotavirus - Symptoms & causes - Mayo Clinic

    Rotavirus is a very contagious virus that causes diarrhea. Before the development of a vaccine, most children had been infected with the virus at least once ...

  7. Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis - Mayo Clinic

    Inclusion Criteria: Men or women aged 18 years and older; Systemic sclerosis, as defined by ACR/EULAR (American College of Rheumatology/European League ...

  8. Publications - Maria Alice V. Willrich, Ph.D. - Mayo Clinic

    ... Factor for MGUS Progression. Clin Chem. 2024 Oct 3; 70 (10):1268-1278. View PubMed; Karsten C, Grannas K, Bergman O, Moverare R, Roforth M, Willrich MAV ...

  9. ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer - Mayo Clinic

    Triple negative is defined as <1% expression for estrogen receptor (ER) and progesterone receptor (PR) and negative for human epidermal growth factor receptor 2 ...

  10. Phase I Clinical Trial of Autologous Adipose Derived Mesenchymal Stem Cells in the Treatment of Paralysis due to Traumatic Spinal Cord Injury

    Taking anti-rheumatic disease medication (including methotrexate or other antimetabolites) within 3 months prior to study enrollment. Ongoing infectious ...